IDN

Intellicheck, Inc. · NASDAQ · Technology · USD · 10-K for 2025, filed 2026-03-19

Figures on this page computed 2026-11-08 12:40 UTC

Last close

2.09USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-19

  • 29.1xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-03-19

    The filing itself

  • 9.4%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-19
    • 10-K for 2025, filed 2026-03-19
    • 10-K for 2025, filed 2026-03-19
    • 10-Q for 2025, filed 2026-08-13
    • 10-K for 2025, filed 2026-03-19
    • 10-Q for 2025, filed 2026-08-13

    The filing itself

  • 5.6%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-19
    • 10-K for 2025, filed 2026-03-19

    The filing itself

  • 19.8%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-19
    • 10-K for 2025, filed 2026-03-19

    The filing itself

  • 0.00Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-19
    • 10-Q for 2025, filed 2026-08-13

    The filing itself

  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

Against its rival

lens 4 of 9

Measure by measure

behind on 1 of 3
  • Profit on each unit of sales5.6%3.8%Ahead

    Higher is better here.

  • Return on the capital it uses9.4%n/an/a

    Higher is better here.

  • Sales growth over five years16.1%n/an/a

    Higher is better here.

  • Debt against equityn/a0.01n/a

    Lower is better here.

  • Gross margin90.4%62.8%Ahead

    Higher is better here.

  • Price against earnings29.1x27.9xBehind

    Lower is better here.

The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.

Against Health In Tech, Inc., IDN is behind on 1 of 3 measures.

Against Health In Tech, Inc., IDN is behind on 1 of 3 measures.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-19

  • Profit on each unit of sales5.6%
    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD

    The filing itself

  • Return on the capital it uses9.4%
    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD

    The filing itself

  • Sales growth over five years16.1%
    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD

    The filing itself

  • Debt against equityn/a

    The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.

    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD

    The filing itself

  • Gross margin90.4%
    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD

    The filing itself

  • Price against earnings29.1x
    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001040896-26-000009
    Reported in
    USD

    The filing itself

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.